You are here

  • Home
  • Archive
  • Volume 19, Issue 1
  • Inconclusive evidence about the efficacy of diverse strategies for intermittent versus daily inhaled corticosteroids for persistent asthma in adults and children

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review and meta-analysis
Inconclusive evidence about the efficacy of diverse strategies for intermittent versus daily inhaled corticosteroids for persistent asthma in adults and children

https://doi.org/10.1136/eb-2013-101249

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests HKR has participated in advisory boards for AstraZeneca and Novartis, received consultancy fees from GlaxoSmithKline, lecture fees from AstraZeneca, Getz Pharma and MSD, research grants from AstraZeneca and GlaxoSmithKline, and is participating in a data monitoring committee for AstraZeneca, GlaxoSmithKline, Merck and Novartis. JMF has received a research grant from GlaxoSmithKline and AstraZeneca and lecture fees from GlaxoSmithKline and AstraZeneca.